| Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Imperial Metals Corp | TSX | III | 8.46 | 634.2 | Upgrade to speculative buy from hold | Gary Lampard | Canaccord Genuity Corp | 10.50 | 24.1% |
| Capstone Mining Corp | TSX | CS | 2.21 | 844.1 | Upgrade to buy from hold | Gary Lampard | Canaccord Genuity Corp | 2.80 | 26.7% |
| Veresen Inc | TSX | VSN | 17.58 | 3,878.6 | Upgrade to buy from hold | Linda Ezergailis | TD Securities | 19.50 | 10.9% |
| Currency Exchange International Corp | TSX | CXI | 15.51 | 83.6 | Initiate with buy | Marc Charbin | Laurentian Bank Securities | 25.00 | 61.2% |
| Wi-Lan Inc | TSX | WIN | 3.54 | 425.5 | Downgrade to sell from hold | Eyal Ofir | Clarus Securities | 3.50 | -1.1% |
Canaccord Genuity Corp upgraded Imperial Metals Corp (TSX: III), engaged in the exploration, development and production of base and precious metals from its mineral properties, to speculative buy from hold with a price target of C$10.50, indicating an upside of 24.1% from current levels.
Capstone Mining Corp (TSX: CS), engaged in the production, development and exploration of base and precious metals, was upgraded by Canaccord Genuity Corp to buy from hold with a price target of C$2.80, indicating an upside potential of 26.7% from current levels.
TD Securities upgraded Veresen Inc (TSX: VSN), engaged in managing its pipeline transportation, midstream services, and power generation businesses, to buy from hold raising its price target to C$19.50 from C$19.00, indicating an upside of 10.9% from current levels.
Coverage on Currency Exchange International Corp (TSX: CXI), engaged in the business of retail and wholesale foreign exchange, was initiated with a buy rating at Laurentian Bank Securities, assigning a 12-month price target of C$25.00, indicating an upside potential of 61.2% from current levels.
Clarus Securities downgraded Wi-Lan Inc (TSX: WIN), engaged in developing, acquiring, and licensing a range of intellectual property, to sell from hold by reducing its price target to C$3.50 from C$4.00, indicating a downside of 1.1% from current levels.
| Company Name | Exchange | Ticker | Last Price | Market Cap | Recommendation | Analyst Name | Rating Company | Target Price |
Upside/ Downside (%) |
|---|---|---|---|---|---|---|---|---|---|
| Home Properties Inc | NYSE | HME | 58.76 | 3,369.5 | Upgrade to hold from sell | David Toti | Cantor Fitzgerald | 62.00 | 5.5% |
| Pandora Media Inc | NYSE | P | 24.18 | 4,992.9 | Upgrade to buy from hold | Victor Anthony | Topeka Capital Markets Inc | 30.00 | 24.1% |
| Proto Labs Inc | NYSE | PRLB | 68.07 | 1,750.7 | Upgrade to buy from hold | Robert Burleson | Canaccord Genuity Corp | 85.00 | 24.9% |
| WhiteWave Foods Co/The | NYSE | WWAV | 35.58 | 6,196.1 | Intiate with outperform | Mitchell B Pinheiro | Imperial Capital LLC | 40.00 | 12.4% |
| Auxilium Pharmaceuticals Inc | NASDAQ | AUXL | 30.00 | 1,510.6 | Downgrade to hold from buy | Difei Yang | R.F. Lafferty & Co | 34.00 | 13.3% |
Cantor Fitzgerald upgraded Home Properties Inc (NYSE: HME), engaged in owning, operating, acquiring and rehabilitating apartment communities, to hold from sell with a price target of $62.00, indicating an upside of 5.5% from current levels.
Pandora Media Inc (NYSE: P), engaged in providing radio services through internet, was upgraded by Topeka Capital Markets Inc to buy from hold with a price target of $30.00, indicating an upside potential of 24.1% from current levels.
Canaccord Genuity Corp upgraded Proto Labs Inc (NYSE: PRLB), a manufacturer of custom parts for prototyping and short-run production, to buy from hold with a price target of $85.00, indicating an upside of 24.9% from current levels.
Imperial Capital LLC initiated coverage on WhiteWave Foods Co/The (NYSE: WWAV), engaged in manufacturing, marketing, distributing and selling plant-based foods and beverages, coffee creamers, beverages, and dairy products throughout North America and Europe, with an outperform rating assigning a 12-month price target of $40.00, indicating an upside potential of 12.4% from current levels.
Auxilium Pharmaceuticals Inc (NASDAQ: AUXL), engaged in developing and marketing therapeutics to urologists, endocrinologists and orthopedists, was downgraded by R.F. Lafferty & Co to hold from buy with a price target of $34.00, implying an upside potential of 13.3% from current levels.
